Blood disorder startup files for $86M IPO

As competitors narrow in, a blood disorder-focused Cambridge startup is planning to raise more funds through an IPO.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.